NCT06770959Not yet recruiting
Frequency of Gastrointestinal and Hepatic Manifestations Among Patients with Multiple Sclerosis, a Clinical Hospital Based Study
Source: ClinicalTrials.gov · Last updated 13 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this work is to identify different pattern of Gastrointestinal and Hepatic symptoms and its Frequency among patients with Multiple Sclerosis
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 27 Dec 2024
- Start date
- Jan 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- Assiut University
- Diseases
- Multiple sclerosis
- NCT number
- NCT06770959
What you commit to
- Study type: Observational
- Planned participants: 80
- From Jan 2025 to the primary completion date, Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 2\_ Presence of other disorder or on medications that may affect the neurological or GIT disorders.
Other
- 3\_ Patients failed to commit to the follow up visits and regular MRI scans 4\_ Patients refused to sign the written informed consent Patients who will meet the inclusion and exclusion criteria will be assessed in the 1st visit by direct interview followed by clinical examination and neuropsychological assessments. Baseline MRI scans will be obtained at the first visit
- \-
Who the study is looking for
- 1- both sex 2- All patients diagnosed MS ( in recovery on DMT) according to the 2017-McDonalds criteria.
- 3- Pt with MS suffer from git and hepatic symptoms not explained by known cause as Hepatitis virus،metabolic disorders as Wilson . hemochromatosis,etc Drug induced , Alcohol , Git symptoms as dysphagia, vomiting,reflux
- 4- An informed consent will be obtained from all the patients, the study will be approved by ethical committee in faculty of Medicine Assiut University
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.